Insightful Science joins forces with Dotmatics to form a leading Cloud-First Scientific R&D company

SEP partner, Keith Davidson
  • Combined company will generate well over $100 million of ARR and signals a significant  transformation in the future of software and data management in research labs.
  • Enabling over one million scientists to improve research and lab efficiency.
  • Facilitating rapid data access and exchange between scientists around the world, ultimately giving customers a competitive edge.

INSIGHTFUL Science, a  leading software provider serving the global life sciences community, announced today that it  has entered into a transaction to acquire Dotmatics, an industry leading cloud-based scientific R&D data management platform.

By integrating Insightful Science’s software applications into Dotmatics cloud-first enterprise  data management solution, the company will provide an end-to-end scientific research platform.  This combination further improves laboratory efficiency and accelerates the pace of scientific  innovation by facilitating more rapid data access, analysis and exchange between scientists  around the world.

Insightful Science is a software company with purpose-built data analysis and bioinformatics  applications for life sciences. The company portfolio serves a diverse set of one million scientists  in academic, corporate, and government institutions around the world. Examples of products  within the Insightful Science portfolio include GraphPad Prism, Geneious DNA data analysis  solutions, SnapGene, and other leading R&D solutions.

Dotmatics is an enterprise scientific informatics SaaS provider that is driving the digitalization of  laboratory data workflows for scientific discovery and innovation across the life sciences,  chemicals and materials industries.

“This announcement signals a significant transformation in the future of software and data  management in research labs,” said Thomas Swalla, CEO of Insightful Science. “Together our  complementary businesses create an end-to-end cloud-first scientific research platform that

stands apart in our collective ability to support data-driven research. We are beyond enthusiastic  about the impact we can have on increasing the speed of scientific innovation, and ultimately  helping to make the world a healthier, cleaner, and better place to live.”

“The number one challenge for pharmaceutical, biotech and chemical innovation companies  today is how to manage the enormous volume — and promise — of data generated in labs,” said  Dr Steve Gallagher, Co-founder and CEO of Dotmatics. “This combination allows us to expand  investments in our Dotmatics platform and strengthen our brand as a leading enterprise  informatics solution provider. We will bring Insightful Science’s leading biologics applications  to our customers, further accelerating their discovery processes. In addition, we have the  opportunity to bring the Dotmatics cloud and collaboration capabilities to the diverse community  of over one million scientists already using Insightful Science tools.”

Digital Transformation to Chart the Course for the Lab of the Future

Scientific research and innovation R&D is in the midst of a pivotal transformation. Scientific  knowledge and growth in pharmaceutical drug discovery and chemicals and materials innovation is increasing at a faster pace than ever before. The research process has been transformed from  transactional and process driven, to data driven. As a result, scientists require increasingly  powerful and integrated informatics tools to analyze ever-more diverse sets of data; and  laboratories and companies need better workflow and data management solutions to help  scientists harness the power of these insights. Companies that own the cleanest, best annotated  data to power their AI analytics and decision making, will be the best placed to be successful in  this new paradigm.

Transaction Details

Insightful Science is a privately held portfolio company of Insight Partners, the leading global  venture capital and private equity firm investing in high-growth technology and software ScaleUp companies.

“The combination of these two entities brings an exciting new solution to market,” said Jeff  Lieberman, Managing Director at Insight Partners. “This announcement and collaboration is a significant opportunity for the life sciences, chemicals and materials industries. We are  incredibly optimistic about the future of the company and its clear path to doing for life sciences and chemical innovation what other market-leading platforms have done in engineering, design,  and later-stage drug development.”

Alastair Hill, Co-founder and CIO of Dotmatics added, “Since initial growth equity investment  by Scottish Equity Partners (SEP), we have been supported to make incredible progress in

scaling our business and driving product innovation. We would like to thank them for their  support as we enter the next exciting stage in Dotmatics’ development, and Jefferies for advising  on the transaction.”

Evercore served as financial advisor and Willkie Farr & Gallagher LLP served as legal advisor to  Insightful Science on the transaction. Jefferies International Ltd served as advisor to Dotmatics.

Scottish Equity Partners (SEP) is a leading European growth equity firm, investing in enterprise and consumer-focused software and technology companies.  

Keith Davidson, Partner at SEP said, “We are pleased to have helped Dotmatics grow into a leading cloud-first scientific R&D data platform. We are excited by the opportunity that lies ahead for the team and wish them every success in the future.”  

Subject to the attainment of regulatory clearances, the transaction is expected to close in Q2 of  2021. Until closing, the companies will continue to operate independently.  

Our brands
Sign up to our newsletter

Subscribe to receive our daily newsletter straight to your inbox.

© 2021 High Growth Scotland. All rights reserved.

Subscribe to receive our daily newsletter straight to your inbox.